US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts

The tariffs, set to increase significantly from August 2029, could impact affordable medicine access. Experts emphasise strengthening domestic manufacturing while preserving global supply chain integration.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *